Pharma Reaserch Prod Co Ltd (214450) — Cash Flow Reinvestment Rate
Pharma Reaserch Prod Co Ltd (214450) has a Cash Flow Reinvestment Rate of 1.20x as of December 2025, reinvesting ₩73.91 Billion (capex ₩7.79 Billion plus investments ₩-66.12 Billion) from operating cash flow of ₩61.53 Billion. See 214450 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pharma Reaserch Prod Co Ltd Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Pharma Reaserch Prod Co Ltd across 11 annual periods. For the full cash flow conversion analysis, see Pharma Reaserch Prod Co Ltd operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Pharma Reaserch Prod Co Ltd (2015–2025)
Year-by-year capital reinvestment analysis for Pharma Reaserch Prod Co Ltd. See 214450 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.95x | ₩174.42 Billion | ₩183.16 Billion | ₩35.78 Billion | ▼ -49.6% |
| 2024 | 1.89x | ₩264.26 Billion | ₩139.88 Billion | ₩38.73 Billion | ▲ +112.0% |
| 2023 | 0.89x | ₩57.86 Billion | ₩64.95 Billion | ₩13.20 Billion | ▲ +78.4% |
| 2022 | 0.50x | ₩29.67 Billion | ₩59.40 Billion | ₩17.76 Billion | ▼ -62.6% |
| 2021 | 1.33x | ₩87.07 Billion | ₩65.30 Billion | ₩20.64 Billion | ▲ +12.4% |
| 2020 | 1.19x | ₩38.42 Billion | ₩32.39 Billion | ₩34.78 Billion | ▲ +110.6% |
| 2019 | 0.56x | ₩10.85 Billion | ₩19.27 Billion | ₩9.59 Billion | ▼ -94.5% |
| 2018 | 10.15x | ₩52.80 Billion | ₩5.20 Billion | ₩28.60 Billion | ▲ +603.0% |
| 2017 | 1.44x | ₩12.35 Billion | ₩8.56 Billion | ₩7.63 Billion | ▲ +200.7% |
| 2016 | 0.48x | ₩3.92 Billion | ₩8.16 Billion | ₩1.96 Billion | ▼ -93.5% |
| 2015 | 7.43x | ₩119.09 Billion | ₩16.02 Billion | ₩462.99 Million | — |